Sarepta Therapeutics, Inc.
Ticker: 873303
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 328.69-0.6% | 330.52-10.7% | 370.04-27.9% | 513.12-16.1% | 611.52+42.3% | 429.77+19.2% | 360.55+0.3% | 359.48 |
| Total Income | 328.69-0.6% | 330.52-10.7% | 370.04-27.9% | 513.12-16.1% | 611.52+42.3% | 429.77+19.2% | 360.55+0.3% | 359.48 |
| EXPENSES | ||||||||
| Expenditure | 387.96+4.2% | 372.37-25.9% | 502.75+1.5% | 495.51-52.6% | 1.0K+134.9% | 444.98+22.4% | 363.63-3.9% | 378.56 |
| Tax | 3.14-74.3% | 12.22+186.7% | -14.10+67.4% | -43.25-167.6% | 63.99+15897.5% | 0.40-94.4% | 7.12+33.6% | 5.33 |
| PROFIT | ||||||||
| PBT | -1.75-100.5% | 343.17+276.8% | -194.05-226.3% | 153.64+140.1% | -383.52-1227.7% | 34.01+150.4% | 13.58-67.2% | 41.45 |
| Net Profit | -4.89-101.5% | 330.96+283.9% | -179.95-191.4% | 196.89+144.0% | -447.51-1431.5% | 33.61+420.3% | 6.46-82.1% | 36.12 |
| KEY METRICS | ||||||||
| OPM % | 4.04%-95.95pp | 100.00%+127.94pp | -27.94%-50.46pp | 22.52%+71.65pp | -49.12%-54.29pp | 5.17%+5.36pp | -0.19%-9.90pp | 9.71% |
| NPM % | -1.49%-101.49pp | 100.00%+148.63pp | -48.63%-87.00pp | 38.37%+111.55pp | -73.18%-81.00pp | 7.82%+6.03pp | 1.79%-8.26pp | 10.05% |
| EPS | -0.05-101.6% | 3.15+275.0% | -1.80-189.6% | 2.01+143.7% | -4.60-1414.3% | 0.35+400.0% | 0.07-81.6% | 0.38 |
Corporate Events
Board MeetingSRPT
20264Jun
Board Meeting
Annual meeting of stockholders to elect directors, approve n…
SEC Filing ↗